NVO - 3.6M Medicare patients could qualify for Wegovy coverage: report
2024-04-24 10:27:55 ET
More on Novo Nordisk
- Novo Nordisk Remains The Better Buy After A Moderate Pullback
- Novo Nordisk: The Moat Won't Last Forever
- Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront
- TikTok to restrict weight loss drug promotion (updated)
- 13 new obesity drugs could hit the market by 2029 amid surging demand